Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma
about
Samarium for osteoblastic bone metastases and osteosarcomaA phase I study evaluating ibritumomab tiuxetan (Zevalin®) in combination with bortezomib (Velcade®) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphoma.Epidermal growth factor receptor vIII expression in U87 glioblastoma cells alters their proteasome composition, function, and response to irradiation.Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesisCopper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma.Beyond Palliation: Therapeutic Applications of 153Samarium-EDTMP.Interleukin-6 counteracts therapy-induced cellular oxidative stress in multiple myeloma by up-regulating manganese superoxide dismutaseRadioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene.CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone diseaseCombination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity.Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myelomaProteasome inhibition causes regression of leukemia and abrogates BCR-ABL-induced evasion of apoptosis in part through regulation of forkhead tumor suppressors.A preclinical model of CD38-pretargeted radioimmunotherapy for plasma cell malignancies.Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.Understanding the hypoxic niche of multiple myeloma: therapeutic implications and contributions of mouse models.Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells.CD38 bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B cell malignancies.153Sm: its use in multiple myeloma and report of a clinical experience
P2860
Q28253337-4411109B-31EE-453E-821D-8695ACC8B4D7Q33396522-C91B52AC-481E-4394-9A76-98CFB5DE6609Q33880422-2D81333E-A193-47D7-8418-3E0CE98659E5Q34411693-8B497B9E-8331-4AFC-AAD3-A572AD51EE81Q35024457-9E91D2E2-98D5-444E-A447-27253886CBC4Q35057029-0778641E-AAD9-47DD-AA62-9FE8079FBD7CQ36002035-228D36D8-6E11-478F-9161-5ACC74085A91Q36007610-9CCBEF35-6D53-4057-A0CF-4C8216C6A3A1Q36177928-1F4FCC2C-094B-4323-BCF9-AE1CE40CD7C9Q36589122-AB7E809C-1848-409C-8AF8-087F26DBC086Q36980287-04D1F638-C6F4-4FA8-9CE0-7F081FC5592EQ37390575-B3F7F562-002E-4A04-B99D-33CF8C4B34B7Q37675882-D7B9F7E8-113E-40D0-90F5-D78826AC49D9Q37940343-37225B11-90D5-430C-B5CB-183D3F43E4BEQ38056889-189A8F4E-79A8-4756-B061-F279FC1EE0DAQ39310876-3A76E707-BECF-4ABD-A434-0D9A744ED886Q47329597-0B1F246F-F941-48F6-8843-F608EBB7C752Q58449064-9E1724A6-8694-4EBF-AB06-5E38C41E50DA
P2860
Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Synergistic activity of the pr ...... opic model of multiple myeloma
@ast
Synergistic activity of the pr ...... opic model of multiple myeloma
@en
type
label
Synergistic activity of the pr ...... opic model of multiple myeloma
@ast
Synergistic activity of the pr ...... opic model of multiple myeloma
@en
prefLabel
Synergistic activity of the pr ...... opic model of multiple myeloma
@ast
Synergistic activity of the pr ...... opic model of multiple myeloma
@en
P2093
P2860
P50
P1433
P1476
Synergistic activity of the pr ...... opic model of multiple myeloma
@en
P2093
Apollina Goel
Susan M Geyer
Suzanne Greiner
P2860
P304
P356
10.1182/BLOOD-2005-09-3870
P407
P577
2006-01-19T00:00:00Z